BioAge Labs (BIOA) Capital Expenditures (2024 - 2026)

BioAge Labs has disclosed Capital Expenditures across 3 years of filings, most recently posting $26000.0 for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $26000.0, down 93.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $319000.0 (down 59.72% YoY), and the FY2025 annual result was $719000.0, up 96.45% from the prior year.
• Capital Expenditures came in at $26000.0 for Q1 2026 at BioAge Labs, down from $112000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $426000.0 in Q1 2025 to a low of $22000.0 in Q3 2025.
• The 3-year median for Capital Expenditures is $73500.0 (2024), against an average of $138875.0.
• Across the five-year window, Capital Expenditures jumped 354.29% in 2025 and plunged 93.9% in 2026, its largest moves.
• BioAge Labs' Capital Expenditures stood at $26000.0 in 2024, then jumped by 330.77% to $112000.0 in 2025, then plunged by 76.79% to $26000.0 in 2026.
• The last three Capital Expenditures figures came in at $26000.0 (Q1 2026), $112000.0 (Q4 2025), and $22000.0 (Q3 2025), per Business Quant data.